Source · Select Committees · Science and Technology Committee (Commons)
Recommendation 19
19
Paragraph: 90
Regulatory divergence on GE phages presents a competitive opportunity for the UK
Conclusion
If the UK government supports the commercial production of genetically engineered (GE) phages, it will inevitably lead to regulatory divergence from the EU. However, we believe this divergence offers the UK an opportunity that should be pursued. This should be part of a clear regulatory and safety licensing regime for phages, if phages are to be exploited for competitive advantage.
Paragraph Reference:
90
Government Response
A response document is linked to this report, dated 1 March 2024. Response attribution to this conclusion has not been verified. Read the response document ↗